Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...

an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body ...

Bayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary endpoints in phase 3 trials.The QUANTI studies examined gadoquatrane at a ...

Computed tomography (CT), Magnetic resonance imaging (MRI), Ultrasound, Positron emission tomography), By Agent Type (Radiopharmaceuticals, Contrast Media, Magnetic Resonance Imaging (MRI) Contrast ...

Obtaining MRI data is a slow process, and acquisition times increase alongside higher spatial resolution when extensive volumetric coverage is needed and/or multiple contrast images or ...

Dong Kook Lifescience lists on KOSDAQ, aims for 300 billion won by 2030 Dong Kook Lifescience seeks to enhance global presence by partnering with AI medical firms and developing innovative imaging ...

particularly MRI and CT scans, is not always an option, because of the high cost, lack of advanced equipment, and their adverse effects on the body: The contrast agents those methods rely on are ...

QUANTI clinical development programme evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and across all ages In the ...

QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult ...